medigraphic.com
SPANISH

Revista Médica Sinergia

Revista Médica Sinergia
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 09

Next >>

Revista Médica Sinergia 2018; 3 (09)

Primary sclerosing cholangitis

Acuña VK
Full text How to cite this article

Language: Spanish
References: 4
Page: 3-8
PDF size: 49.76 Kb.


Key words:

cholangitis, gall bladder, fibrosis, extrahepatic, liver, intestine.

ABSTRACT

Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by a progressive course of cholestasis with inflammation and fibrosis of the intrahepatic and extrahepatic bile ducts. PSC is strongly associated (60-80%) with inflammatory bowel disease (IBD), mainly ulcerative colitis, and is often complicated by the development of cholangiocarcinoma. Most individuals have no symptoms (44-56%), and the presence of primary sclerosing cholangitis is recognized only because of abnormally elevated blood levels of liver enzymes that often are performed along with a routine physical examination.


REFERENCES

  1. Konstantinos N. Lazaridis, MD. (2016). Colangitis esclerosante primaria. The New England Journal of Medicine, 375, 1161-1170.

  2. Siddharth Singh. (2013). Colangitis Esclerosante Primaria: Diagnóstico, Pronóstico y Manejo. Clinical Gastroenterology and Hepatology, 11, 898-907.

  3. Nieun Seo, MD. (2016). Colangitis esclerosante: características clínico-patológicas, espectro de imágenes y enfoque sistémico para el diagnóstico diferencial. Korean Journal of Radiology, 17, 25.

  4. Mark Feldman. (2016). Sleisenger y la enfermedad gastrointestinal y hepática de Fordtran. Philadelphia, PA: Saunders / Elsevier.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Médica Sinergia. 2018;3